Pharmaceutical companies have a substantial influence on public health policy. Through lobbying and funding research, they can shape policies related to drug approval, pricing, and distribution. While this can lead to advancements in public health, it also raises concerns about potential conflicts of interest and the prioritization of profit over public health.
